Systemic lupus erythematosus and Optic atrophy

Summary:

Optic atrophy is found among people with Systemic lupus erythematosus, especially for people who are female, 10-19 old.

The study analyzes which people have Optic atrophy with Systemic lupus erythematosus. It is created by eHealthMe based on reports of 11 people who have Systemic lupus erythematosus from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Systemic lupus erythematosus?

Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue) is found to be associated with 1,087 drugs and 1,645 conditions by eHealthMe. Check the latest studies of Systemic lupus erythematosus.

What is Optic atrophy?

Optic atrophy (the loss of a proportion of optic disc nerve fibres) is found to be associated with 248 drugs and 453 conditions by eHealthMe. Check the latest studies of Optic atrophy.



On Aug, 04, 2026

11 people who have Systemic Lupus Erythematosus and Optic Atrophy are studied.

Would you have Optic atrophy when you have Systemic lupus erythematosus?

Gender of people who have Systemic Lupus Erythematosus and experienced Optic Atrophy *:

  • female: 66.67 %
  • male: 33.33 %

Age of people who have Systemic Lupus Erythematosus and experienced Optic Atrophy *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 50.0 %
  • 20-29: 0.0 %
  • 30-39: 12.5 %
  • 40-49: 0.0 %
  • 50-59: 37.5 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 4 people, 36.36%
  2. Skin Bacterial Infection: 2 people, 18.18%
  3. Rashes (redness): 2 people, 18.18%
  4. Cellulitis (infection under the skin): 2 people, 18.18%
  5. Optic Neuritis (optic nerve inflammation): 1 person, 9.09%
  6. High Blood Pressure: 1 person, 9.09%
  7. Disseminated Cryptococcosis (one of the acquired immune deficiency syndrome defining criteria and the most common cause of life threatening meningitis): 1 person, 9.09%

Common drugs taken by these people *:

  1. Vancomycin: 2 people, 18.18%
  2. Tacrolimus: 1 person, 9.09%
  3. Rituxan: 1 person, 9.09%
  4. Mycophenolate Mofetil: 1 person, 9.09%
  5. Methotrexate: 1 person, 9.09%
  6. Cyclosporine: 1 person, 9.09%
  7. Cyclophosphamide: 1 person, 9.09%
  8. Cellcept: 1 person, 9.09%
  9. Azathioprine: 1 person, 9.09%
  10. Amlodipine: 1 person, 9.09%

Common symptoms for these people *:

  1. Meningitis Cryptococcal (bacterial inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges): 4 people, 36.36%
  2. Disseminated Cryptococcosis (one of the acquired immune deficiency syndrome defining criteria and the most common cause of life threatening meningitis): 4 people, 36.36%
  3. Acquired Pigmented Retinopathy (sudden acquired retinal degeneration): 3 people, 27.27%
  4. Atrophy (wasting away of a part of the body): 2 people, 18.18%
  5. Blindness: 2 people, 18.18%
  6. Intracranial Pressure Increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid): 2 people, 18.18%
  7. Infection: 2 people, 18.18%
  8. Cerebral Atrophy (decrement in size of brain): 2 people, 18.18%
  9. Cerebral Ventricle Dilatation (enlargement of ventricle of brain): 2 people, 18.18%
  10. Fungal Peritonitis (fungal infection silk like membrane lines inner abdominal wall): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Optic atrophy?

- Check whether Optic atrophy is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Optic atrophy:

All the conditions that are associated with Optic atrophy:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Optic atrophy and Systemic lupus erythematosus, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: